Secondary prevention in patients after hospitalisation due to coronary artery disease: What has changed since 2006?

Kardiologia Polska

Volumn 72, Issue 4, 2014, Pages 355-362

  Jankowski, Piot ^a   Czarnecka, Danuta ^a   Łysek, Radoslaw ^a   Skrzek, Agnieszka ^a   Smaś Suska, Monika ^a   Mazurek, Adam ^a   Brzozowska Kiszka, Malgorzata ^a   Wolfshaut Wolak, Renata ^a   Surowiec, Slawomir ^a   Bogacki, Piotr ^b   Bryniarska Mirek, Ewa ^c   Bryniarski, Leszek ^a   Grodecki, Janusz ^d   Nessler, Jadwiga ^a   Olszowska, Maria ^a   Podolec, Piotr ^a   Kawecka Jaszcz, Kalina ^a   Paja̧k, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b L Rydygier District Hospital   (Poland)

^c J Dietl Hospital   (Poland)

^d Department of Cardiology   (Poland)

Author keywords

Coronary artery disease; Risk factors; Secondary prevention

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SARTAN DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; POLAND; PRESCRIPTION; REVIEW; SECONDARY PREVENTION; SMOKING; SMOKING CESSATION; COMPARATIVE STUDY; FORECASTING; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERY DISEASE; FEMALE; FORECASTING; HUMANS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; POLAND; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION;

EID: 84928605260     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2013.0350     Document Type: Review

References (22)

1. World Health Organization. The World Health Report. WHO, Genewa 2008; http://www.who.int/whr/2008/whr08-en.pdf
2. World Health Organization Regional Office for Europe (HFA-DB), European health for all database. July 2012
3. De Bacquer D, Dallongeville J, Kotseva K et al. Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE Risk Categories. Int J Cardiol, 2013; 168: 910-914
4. Simpson CR, Buckley BS, McLernon DJ et al. Five-year prognosis in an incident cohort of people presenting with acute myocardial infarction. PLoS One, 2011; 6: e26573
5. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J, 2012; 33: 1635-1701
6. Kawecka-Jaszcz K, Pajak A, Jankowski P. Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part I. Genesis and objectives. Przegl Lek, 2001; 58: 953-955
7. Kawecka-Jaszcz K, Jankowski P, Paja̧k A et al. Cracovian program for secondary prevention of ischaemic heart disease. Part III. Secondary prevention of ischaemic heart disease after discharge. Przegl Lek, 2001; 58: 964-968
8. Jankowski P, Kawecka-Jaszcz K, Pajak A et al. Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000. Przegl Lek, 2003; 60: 142-146
9. Kotseva K, Wood D, De Backer GD et al.; The EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. EJCPR, 2009; 16: 121-137
10. Jankowski P, Kawecka-Jaszcz K, Paja̧k A et al. Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EuroASPIRE II and EuroASPIRE III surveys. Kardiol Pol, 2009; 67: 970-977
11. Paja̧k A, Jankowski P, Kawecka-Jaszcz K. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Comparison of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EUROASPIRE II and EUROASPIRE III surveys. Kardiol Pol, 2009; 67: 1353-1359
12. Jankowski P, Czarnecka D, Wolfshaut-Wolak R et al. Age, sex, and secondary prevention of ischaemic heart disease in everyday practice. Kardiol Pol, 2013; 71: 1251-1259
13. Silagy C, Lancaster T, Stead L et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004; 3: CD000146
14. Kawecka-Jaszcz K, Jankowski P, Pajak A. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Int J Cardiol, 2003; 91: 15-23
15. Śliż D, Filipiak KJ, Naruszewicz M et al. Standards of statin usage in Poland in high-risk patients: 3ST-POL study results. Kardiol Pol, 2013; 71: 253-259
16. Zdrojewski T, Rutkowski M, Bandosz P et al. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol, 2013; 71: 381-392
17. Poloński L, Ga̧sior M, Gierlotka M et al. Polish Registry of Acute. Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol, 2007; 65: 861-872
18. Grajek S, Lesiak M, Araszkiewicz A et al. Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry). Kardiol Pol, 2008; 66: 154-163
19. Yusuf S, Islam S, Chow CK et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet, 2011; 378: 1231-1243
20. Heran BS, Chen JM, Ebrahim S at al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev, 2011; 7: CD001800
21. Brown JP, Clark AM, Dalal H et al. Patient education in the management of coronary heart disease. Cochrane Database Syst Rev, 2011; 12: CD008895
22. Jankowski P, Niewada M, Bochenek A et al. Optimal Model of Comprehensive Rehabilitation and Secondary Prevention. Kardiol Pol, 2013; 71: 995-1003.